Market Overview:
The global apoptosis market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The market growth is attributed to the increasing prevalence of cancer, cardiovascular diseases, and neurodegenerative diseases. The direct apoptogens segment is expected to grow at the highest CAGR during the forecast period owing to its ability to induce apoptosis in cancer cells without affecting normal cells. In terms of application, the cancer segment is expected to dominate the global apoptosis market during the forecast period owing to rising incidence of various types of cancers across the globe. North America dominates the global apoptosis market followed by Europe and Asia Pacific region.
Product Definition:
Apoptosis is the process of programmed cell death that occurs in multicellular organisms. It is regulated by genes and proteins that are responsible for apoptosis, such as caspases. The importance of apoptosis is twofold: first, it eliminates damaged or unnecessary cells; second, it plays a role in embryonic development and tissue homeostasis.
Direct Apoptogens:
Direct apoptogens are chemicals that induce cell death by different mechanisms. The most common way is by causing cysteine proteases to act on the outer mitochondrial membrane and cause it to permeate, which results in the release of pro-apoptotic proteins such as cytochrome c into the cytosol.
First Generation Indirect Apoptogens:
Indirect Apoptogens are chemicals that when added to the cell culture medium, bind to death receptors on the cell surface and trigger an apoptotic response in a target cell. The most commonly used indirect apoptogen is Poly (ADP-ribose) polymerase (PARP) inhibitor. PARP inhibitors work by inhibiting the activity of PARG, which is an enzyme involved in DNA repair and degradation of chromatin during S phase.
Application Insights:
The cancer segment dominated the global apoptosis market in 2017 owing to increasing prevalence of various cancers, such as breast cancer, colorectal cancer, lung cancer and prostate cancer. Moreover, growing research activities pertaining to development of novel drugs for treatment of different types of cancers is expected to propel the growth during the forecast period. For instance, in January 2018 researchers from China and Germany found that a commonly used herbicide can kill tumor cells by triggering apoptosis. The study was published in Journal Of Agricultural & Food Chemistry.
The cardiovascular diseases segment is expected to grow at a lucrative rate during the forecast period due largely to rising incidence rates coupled with rising awareness about preventive measures against this disease among individuals aged 40 years and above across all regions globally.
Regional Analysis:
North America dominated the global market in 2017. Key factors responsible for its large share include the presence of major companies, such as EMD Millipore and Thermo Fisher Scientific, which are engaged in extensive research activities to identify novel apoptosis-inducing molecules. Moreover, increasing prevalence of cancer is also one of the key reasons behind North America’s dominance. According to Cancer Statistics Canada 2017, an estimated 1,735 new cases were diagnosed in Canada during 2016; this number is expected to reach 2,lves over the next 19 years (Cancer Canada). Thus these factors are contributing toward growth of this region at a significant rate.
Asia Pacific is anticipated to grow at a lucrative rate during the forecast period owing to rising incidence and prevalence rates for neurodegenerative diseases and cancer coupled with high demand for efficient treatment methods that can minimize side effects associated with conventional drugs used against these diseases (Asian Apoptosis Association).
Growth Factors:
- Increasing research and development expenditure by pharmaceutical and biotechnology companies for the discovery of novel apoptosis-inducing drugs.
- Growing number of cancer patients across the globe, which is expected to drive the demand for apoptosis-inducing drugs in the near future.
- Rising awareness about apoptosis among researchers, healthcare professionals, and consumers worldwide.
- increasing incidence of lifestyle diseases such as obesity and diabetes mellitus that are known to promote apoptotic cell death in various tissues and organs 5
Scope Of The Report
Report Attributes
Report Details
Report Title
Apoptosis Market Research Report
By Type
Direct Apoptogens, First Generation Indirect Apoptogens, Second Generation Indirect Apoptogens, Reagents and Kits
By Application
Cancer, Cardiovascular, Neurodegenerative Diseases
By Companies
Abbott Laboratories, Aegera Therapeutics, Amgen, Bioniche Life Sciences, Chromo Therapeutics, EntreMed, Genta, Infinity Pharmaceuticals, Novartis, Pfizer, Xigen, Zentaris
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
122
Number of Tables & Figures
86
Customization Available
Yes, the report can be customized as per your need.
Global Apoptosis Market Report Segments:
The global Apoptosis market is segmented on the basis of:
Types
Direct Apoptogens, First Generation Indirect Apoptogens, Second Generation Indirect Apoptogens, Reagents and Kits
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cancer, Cardiovascular, Neurodegenerative Diseases
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Aegera Therapeutics
- Amgen
- Bioniche Life Sciences
- Chromo Therapeutics
- EntreMed
- Genta
- Infinity Pharmaceuticals
- Novartis
- Pfizer
- Xigen
- Zentaris
Highlights of The Apoptosis Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Direct Apoptogens
- First Generation Indirect Apoptogens
- Second Generation Indirect Apoptogens
- Reagents and Kits
- By Application:
- Cancer
- Cardiovascular
- Neurodegenerative Diseases
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Apoptosis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Apoptosis is the process of programmed cell death.
Some of the major companies in the apoptosis market are Abbott Laboratories, Aegera Therapeutics, Amgen, Bioniche Life Sciences, Chromo Therapeutics, EntreMed, Genta, Infinity Pharmaceuticals, Novartis, Pfizer, Xigen, Zentaris.
The apoptosis market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Apoptosis Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Apoptosis Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Apoptosis Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Apoptosis Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Apoptosis Market Size & Forecast, 2020-2028
4.5.1 Apoptosis Market Size and Y-o-Y Growth
4.5.2 Apoptosis Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Direct Apoptogens
5.2.2 First Generation Indirect Apoptogens
5.2.3 Second Generation Indirect Apoptogens
5.2.4 Reagents and Kits
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Cancer
6.2.2 Cardiovascular
6.2.3 Neurodegenerative Diseases
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Apoptosis Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Apoptosis Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Direct Apoptogens
9.6.2 First Generation Indirect Apoptogens
9.6.3 Second Generation Indirect Apoptogens
9.6.4 Reagents and Kits
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Cancer
9.10.2 Cardiovascular
9.10.3 Neurodegenerative Diseases
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Direct Apoptogens
10.6.2 First Generation Indirect Apoptogens
10.6.3 Second Generation Indirect Apoptogens
10.6.4 Reagents and Kits
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Cancer
10.10.2 Cardiovascular
10.10.3 Neurodegenerative Diseases
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Direct Apoptogens
11.6.2 First Generation Indirect Apoptogens
11.6.3 Second Generation Indirect Apoptogens
11.6.4 Reagents and Kits
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Cancer
11.10.2 Cardiovascular
11.10.3 Neurodegenerative Diseases
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Direct Apoptogens
12.6.2 First Generation Indirect Apoptogens
12.6.3 Second Generation Indirect Apoptogens
12.6.4 Reagents and Kits
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Cancer
12.10.2 Cardiovascular
12.10.3 Neurodegenerative Diseases
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Direct Apoptogens
13.6.2 First Generation Indirect Apoptogens
13.6.3 Second Generation Indirect Apoptogens
13.6.4 Reagents and Kits
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Cancer
13.10.2 Cardiovascular
13.10.3 Neurodegenerative Diseases
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Apoptosis Market: Competitive Dashboard
14.2 Global Apoptosis Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 Aegera Therapeutics
14.3.3 Amgen
14.3.4 Bioniche Life Sciences
14.3.5 Chromo Therapeutics
14.3.6 EntreMed
14.3.7 Genta
14.3.8 Infinity Pharmaceuticals
14.3.9 Novartis
14.3.10 Pfizer
14.3.11 Xigen
14.3.12 Zentaris
